USSTOCK.TODAY
Pre-Market
Log in Sign up

Merck outperforms S&P 500 with nearly 40% stock price increase

The Motley Fool +1 · ·by G4L

MRK Merck & Co Inc
$137.78 -3.90%
View chart & analysis →
  1. 1Merck's stock price has recorded a nearly 40% increase so far in 2026.
  2. 2Merck achieved $8.6 billion in Keytruda sales in the third quarter.
  3. 3Merck currently shows a forward price-to-earnings ratio of 16.

So what's the key point?

Merck's stock price rose by 40%, significantly outperforming the market. The company saw strong results with key drug sales reaching $8.6 billion.

Source The Motley Fool +1 · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →